This supplement features FDA updates for the treatment of myeloid malignancies, new questions in acute myeloid leukemia, and more.
This supplement features a look at the future of Hodgkin lymphoma treatment, the latest approvals for lymphoid malignancies, and more.
In this special edition, we take a look at the latest updates in classical hematology, from a advances in gene therapy for hemophilia to a debate about intravenous iron in pregnant women with iron-deficiency anemia, and more.
This supplement features FDA updates, clinical trials, and the latest research in myeloid malignancies.
This supplement features a look at controversies in myeloma treatment, the future of immunotherapy for lymphoma, newly approved and investigational therapies, and more.
This special edition features a closer look at immunotherapy, including the challenges and obstacles of clinical trials, the state of CAR T-cell therapy, and immunotherapies in the development pipeline.
This special edition features updates in the world of myeloid malignancies, including a review of investigational treatment options and news from recent hematologic conferences.
This supplement features FDA updates, clinical trials, policy updates, and the latest research in hematologic rare diseases.
This special edition features advice and resources for trainees and fellows.
This supplement features updated information on late-breaking drug approvals for bleeding disorders, leukemia, and myeloma.
12Page 1 of 2